Linked Data API

Show Search Form

Search Results

1695116
unstar this property registered interest false more like this
star this property date less than 2024-03-11more like thisremove minimum value filter
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Breast Cancer: Screening more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential merits of (a) lowering the breast cancer screening age to 40 and (b) including a breast cancer risk assessment in the first appointment. more like this
unstar this property tabling member constituency Carshalton and Wallington remove filter
star this property tabling member printed
Elliot Colburn more like this
unstar this property uin 17983 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2024-03-19more like thismore than 2024-03-19
star this property answer text <p>The UK National Screening Committee (UK NSC) currently recommends that all women aged 50 years old to 71 years old are invited for breast screening every three years. A trial, AgeX is looking at the impact of increasing or decreasing, or both, the screening age for the breast screening programme. When the results from this trial are available, the UK NSC will review the findings. The UK NSC plans to review the evidence for risk stratification in breast screening to tailor it more closely to an individual’s risk of cancer, rather than the current population-based approach.</p> more like this
star this property answering member constituency Pendle more like this
star this property answering member printed Andrew Stephenson more like this
star this property question first answered
less than 2024-03-19T15:37:13.983Zmore like thismore than 2024-03-19T15:37:13.983Z
unstar this property answering member
4044
unstar this property label Biography information for Andrew Stephenson more like this
star this property tabling member
4775
star this property label Biography information for Elliot Colburn more like this
1695117
unstar this property registered interest false more like this
star this property date less than 2024-03-11more like thisremove minimum value filter
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Breast Cancer: Screening more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what recent assessment her Department has made of the potential merits of introducing (a) a risk assessment and (b) a breast density assessment during a women's first breast cancer screening appointment. more like this
unstar this property tabling member constituency Carshalton and Wallington remove filter
star this property tabling member printed
Elliot Colburn more like this
unstar this property uin 17984 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2024-03-19more like thismore than 2024-03-19
star this property answer text <p>The UK National Screening Committee (UK NSC) plans to review the evidence for risk stratification in breast screening, to tailor it more closely to an individual’s risk of cancer, rather than the current population-based approach.</p><p> </p><p>In 2019, the UK NSC reviewed the benefit of additional screening with ultrasound after a negative mammography screening, for women with dense breasts. The Committee concluded that there was insufficient evidence to recommend additional ultrasound screening at that time.</p><p> </p><p>The Breast Screening Risk Adaptive Imaging for Density trial is looking into the use of supplementary imaging techniques for women within the standard breast screening programme, who are found to have radiographically dense breast tissue. The UK NSC will review this evidence when it becomes available.</p> more like this
star this property answering member constituency Pendle more like this
star this property answering member printed Andrew Stephenson more like this
star this property question first answered
less than 2024-03-19T15:29:57.683Zmore like thismore than 2024-03-19T15:29:57.683Z
unstar this property answering member
4044
unstar this property label Biography information for Andrew Stephenson more like this
star this property tabling member
4775
star this property label Biography information for Elliot Colburn more like this
1695115
unstar this property registered interest false more like this
star this property date less than 2024-03-11more like thisremove minimum value filter
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Breast Cancer: Screening more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential merits of (a) 3D mammography and (b) other new screening technologies to support the early diagnosis of breast cancer. more like this
unstar this property tabling member constituency Carshalton and Wallington remove filter
star this property tabling member printed
Elliot Colburn more like this
unstar this property uin 17982 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2024-03-19more like thismore than 2024-03-19
star this property answer text <p>The UK National Screening Committee (UK NSC) is aware of research into the use of three-dimensional (3D) mammography and the growing interest to use artificial intelligence (AI) in the National Health Service breast screening programme. Guidance has been published on GOV.UK on the use of Tomosynthesis 3D imaging in a clinical trial setting as part of the NHS breast screening programme.</p><p>The UK NSC had also worked with Health Technology Assessments to design an evaluation of existing AI in a prospective study to look at whether it could be used to read breast screening mammograms.</p><p>There are currently no plans to adopt these technologies, but evidence to inform a UK NSC decision on the use of 3D mammography and AI in the NHS breast screening programme will be reviewed by the Committee when available.</p> more like this
star this property answering member constituency Pendle more like this
star this property answering member printed Andrew Stephenson more like this
star this property question first answered
less than 2024-03-19T14:57:39.543Zmore like thismore than 2024-03-19T14:57:39.543Z
unstar this property answering member
4044
unstar this property label Biography information for Andrew Stephenson more like this
star this property tabling member
4775
star this property label Biography information for Elliot Colburn more like this